Mitochondria-Specific Agents for Photodynamic Cancer Therapy: A Key Determinant to Boost the Efficacy

Area of Science:

• Biomedical Engineering
• Oncology
• Photochemistry

Background:

• Photodynamic therapy (PDT) is a cancer treatment that uses light to activate drugs, producing cell-killing oxygen species.
• Mitochondria are key targets for enhancing PDT due to their critical role in cell function and death.
• Traditional PDT faces challenges such as limited specificity and efficacy.

Purpose of the Study:

• To review recent advances in mitochondria-targeted photodynamic therapy (Mt-PDT) for cancer treatment.
• To discuss design principles, therapeutic strategies, and performance of Mt-PDT agents.
• To explore agent-free Mt-PDT and combination strategies with other anticancer approaches.

Main Methods:

• Literature review of recent research on Mt-PDT.
• Analysis of mitochondrial targeting design principles and strategies.
• Evaluation of therapeutic performance of various Mt-PDT agents and approaches.

Main Results:

• Numerous mitochondria-targeting agents have been developed to improve PDT efficacy.
• Mt-PDT can directly destroy mitochondria or activate mitochondria-mediated cell death pathways.
• Combinations of Mt-PDT with other anticancer strategies demonstrate significant advantages.

Conclusions:

• Mt-PDT is a promising strategy for enhancing anticancer effectiveness by targeting mitochondria.
• Further development of mitochondria-specific agents and strategies is crucial.
• Future research should focus on overcoming existing challenges and optimizing Mt-PDT applications.